Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on Jun 10, 2021 7:18pm
214 Views
Post# 33369842

RE:We lost 1/2 our share price since launch..

RE:We lost 1/2 our share price since launch..They better be crazy busy behind the scenses closing deals and getting contracts finalized cause all this silence is beating the heck out of the shareprice.  Every forecast they make they miss by months and years - complete insanity.   

If they don't deliver something major by the end of July like their "anticipated" milestone list items Howard should be booted to the curb.  It is crazy the length of time it takes them to figure things out and get something done.  Even the Phase I for TFC-039 at 7 years! (almost to the day) is probably double what it normally takes to run a compound through its paces - or at least a couple years over the norm at a minimum.  Everything they touch and do just gets bogged down with their incompetence.       

Memories.....
https://stockhouse.com/news/press-releases/2014/06/03/sirona-biochem-announces-wanbang-biopharmaceutical-s-launch-of-pre-clinical
<< Previous
Bullboard Posts
Next >>